Lactobacillus casei HY7213 ameliorates cyclophosphamide-induced immunosuppression in mice by activating NK, cytotoxic t cells and macrophages

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 3, 2013, Pages 396-402

  Jang, Se Eun ^a   Joh, Eun Ha ^a   Ahn, Young Tae ^b   Huh, Chul Sung ^b   Han, Myung Joo ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea Yakult Co   (South Korea)

Author keywords

Cyclophosphamide; Immunopotentiation; Lactic acid bacteria; Lactobacillus casei HY7213; Macrophage

Indexed keywords

CONCANAVALIN A; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; HY 7213; IMMUNOMODULATING AGENT; INTERLEUKIN 2; LEVAMISOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOPOTENTIATION; IMMUNOSUPPRESSIVE TREATMENT; LACTOBACILLUS CASEI; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN WEIGHT; T LYMPHOCYTE; TREATMENT DURATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CYCLOPHOSPHAMIDE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LACTOBACILLUS CASEI; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84877856107     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.789055     Document Type: Article

References (31)

1. Carvalho C, Santos RX, Cardoso S, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009;16:3267-3285
2. Pass J, Carrie D, Boylan N, et al. Role of hepatic cytochrome P450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome P450 reductase null mouse. Cancer Res 2005;65:4211-4217
3. Singh K.P., Gupta RK, Shau H, Ray P.K. Effect of ASTA-Z 7575 (INN maphosphamide) on human lymphokine-activated killer cell induction. Immunopharmacol Immunotoxicol 1993;15:525-538
4. Gazit Z, Kedar E. Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice. Cancer Immunol Immunother 1994;38:243-252
5. Hoover SK, Barrett SK, Turk TM, et al. Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity. Cancer Immunol Immunother 1990;31:121-127
6. OConnell MJ. North central cancer treatment group - Mayo clinic trials in colon cancer. Semin Oncol 2001;28:4-8
7. Bagga A, Hari P. Levamisole-induced vasculitis. Ped Nephrol 2000; 14:1057-1058
8. Joly C, Palisse M, Ribbe D, et al. Acute levamisole poisoning. Presse Med 1988;27:717
9. Palcoux JB, Niaudet P, Goumy P. Side effects of levamisole in children with nephrosis. Ped Nephrol 1994;8:263-264
10. Cho J, Lee D, Yang C, et al. Microbial population dynamics of kimchi, a fermented cabbage product. FEMS Microbiol Lett 2006; 257:262-267
11. Collins MP, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:s1052-s1057
12. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984;86:174-193
13. Masood MI, Qadir MI, Shirazi JH, Khan IU. Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol 2011;37: 91-98
14. Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 1999;116:1246-1260
15. Lee IA, Bae EA, Lee JH, et al. Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice. Inflamm Res 2010;59:359-368
16. Foligné B, Deutsch SM, Breton J, et al. Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl Environ Microbiol 2010;76l: 8259-8264
17. De Simone C, Vesely R, Bianchi Salvadori B, Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993;27:23-28
18. Elmadfa I, Klein P, Meyer AL. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proc Nutr Soc 2010;69:416-420
19. Bujalance C, Moreno E, Jimenez-Valera M, Ruiz-Bravo A. A probiotic strain of Lactobacillus caseistimulates lymphocyte responses in immunologically intact and immunocompromised mice. Int J Food Microbiol 2007;113:28-34
20. Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation - the key step of inflammation. Biochem Pharmacol 2011;82:278-286
21. Joh EH, Gu W, Kim DH. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-B and M.A.*PK pathways. Biochem Pharmacol 2012;84:331-340
22. Mace EM, Monkley SJ, Critchley DR, Takei F. A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells. J Immunol 2009;182: 948-956
23. Zhu XL, Chen AF, Lin ZB. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 2007;111:219-226
24. Weeks BA, Keisler AS, Myrvik QN, Warinner JE. Differential uptake of neutral red by macrophages from three species of estuarine fish. Dev Comp Immunol 1987;11:117-124
25. Won TJ, Kim B, Oh ES, et al. Immunomodulatory activity of Lactobacillus strains isolated from fermented vegetables and infant stool. Can J Physiol Pharmacol 2011;89:429-434
26. Kato I, Yokokura T, Mutai M. Macrophage activation by Lactobacillus casei in mice. Microbiol Immunol 1983;41:611-618
27. Shida K, Suzuki T, Kiyoshima-Shibata J, et al. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol 2006;13: 997-1003
28. Dong H, Rowland I, Tuohy KM, et al. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clin Exp Immunol 2010;161: 378-388
29. Ishida-Fujii K, Sato R, Goto S, et al. Prevention of pathogenic Escherichia coli infection in mice and stimulation of macrophage activation in rats by an oral administration of probiotic Lactobacillus casei I-5. Biosci Biotechnol Biochem 2007;71: 866-873
30. Matsuzaki T, Yokokura T, Azuma I. Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice. Cancer Immunol Immunother 1987;24:99-105
31. Silveira EM, Rodrigues MF, Krause MS, et al. Acute exercise stimulates macrophage function: possible role of NF-kappaB pathways. Cell Biochem Funct 2007;25:63-73